Quiq reports on key questions surrounding AI, covering its capabilities, risks, ethical challenges, and future implications ...
Company to showcase next-generation PCIe 6.0 CopprLink™ cable adapters and new 4UPro-Max expansion accelerator for ultra-low latency, high-wattage AI workloads at Booth 2111 Latest innovation from OSS ...
Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets soluble amyloid beta oligomers (AβOs) for the treatment of Alzheimer ...
This year, Oklahoma took a major step forward in improving health care access, especially for rural communities like mine in Drumright.
YourStory presents the daily news roundup from the Indian startup ecosystem and beyond. Here's the roundup for Monday, ...
Discover whether the Wuffy Robot Dog is worth buying in 2025. See features, benefits, price, safety, and real customer insights before you order. Wuffy Wuffy New York City, NY, Nov. 15, 2025 (GLOBE ...
Stephen Johnston, Ph.D., from the Royal Marsden NHS Foundation Trust in London, and colleagues reported the primary OS results for patients with HR-positive, HER2-negative, node-positive, high-risk ...
The UK’s regulator, the MHRA, will be running five pilot dialogues as part of its first year exploring a real-world evidence scientific dialogue programme. The five were selected from 25 expressions ...
New Royalty Investments On September 25, 2025, Ligand purchased the global royalty rights to AT220, an Arestat®-enhanced biosimilar product marketed by a global pharmaceutical company, and all ...
Are you stuck in a chest-building rut? Use this unconventional pec workout to reignite your progress. It works because it’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback